Clover Health Investments (CLOV) reports Q4 results; offers guidance

Clover Health Investments (NASDAQ: CLOV) reported Q4 Revenue for the quarter at $510.3 million versus the consensus estimate of $474.01 million.

GUIDANCE:

Clover Health Investments sees FY2024 Insurance revenue of $1.25-1.3 billion. Insurance MCR of 79% - 83%. Adjusted EBITDA (Non-GAAP) of ($20) million - $20 million

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance
• Investing.com’s stocks of the week